Abstract Mesangial cells are responsible for the syn-proteinases ( MMPs) [1] .
medium (Gibco, UK ), which contains 11 mM glucose with 807 bp [10] ; for TIMP-1, 142-170 and 664-693, 552 bp [11] ;
for TIMP-2, 349-369 and 913-933, 585 bp [8] ; for 10% FCS, 100 mg/ml penicillin, 100 mg/ml streptomycin, and 2.5 mg/ml fungizon. Between passage 10 and 14, 3×106 cells a1( IV )COLL, primers RE1 from exon 49 and CP-4 from exon 52, 413 bp (generous gift of Dr K. Tryggvason, Oulu) were seeded in a 225 cm2 flask (Bibby Sterilin Ltd, UK ) and cultured for 8 days with and without 100 mg/ml LMW [12] . b 2 -Microglobulin was used as an internal control (housekeeping gene) for determining transcript levels by heparin ( Fluxum, Alfa Wassermann SpA, Italy), 30 mM glucose (final concentration), or 100 mg/ml LMW heparin PCR-based methods. Primers for amplification of b 2 -microglobulin cDNA were 901-925 and 1410-1434, 150 bp [ 8] . plus 30 mM glucose, at 37°C and 5% CO 2 . The culture medium was renewed every 2 days. Primary and SV40 Primers for murine were different in the case of MMP-1, 1027-1046 and 1491-1510, 484 bp [13] ; MMP-3 (in substitutransgenic murine cells (MMCs) ( ATCC) were obtained and grown as described [ 6 ] .
tion of MMP-10 ), 
RNA extraction
from two exons separated by one or more intronic sequences, to identify possible amplicons among contaminating genAt the end of incubation, the cells were rinsed with PBS omic DNA. without calcium and magnesium, trypsinized and pelleted. The total RNA was extracted from cellular pellet using the RNAzol method ( Ultraspec RNA, Biotecx, USA). RNA
Optimization of PCR
yield and purity were measured by spectrophotometric determinations at 260 and 280 nm.
Preliminary linear range-finding experiments were performed to determine the range of cDNA dilutions over which PCR cDNA synthesis amplification was linear for each target molecule. cDNA corresponding to 250 ng RNA was serially diluted 152 and Reverse transcription of 2.5 mg total RNA using 0.2 mg oligo-PCR amplified using fixed reaction conditions (see above). dT primer was performed for 1 h at 42°C using 25 U of AMV reverse transcriptase (Boehringer Mannheim, Italia SpA, Milano, Italy) in 50 mM Tris (pH 8.3), 75 mM KCl, Detection and analysis of amplicons
, 10 mM DTT, 1 U RNasin (Promega Corporation, Madison, USA) and 1 mM each of dATP, Following amplification, 20 ml aliquots were analysed by 1% dGTP, dCTP and dTTP. For removal of RNA from agarose gel electrophoresis in TBE buffer (0.09 M Tris, RNA-cDNA hybrids, produced by first-strand cDNA syn-0.09 M boric acid, 2 mM EDTA, pH 8) and PCR products thesis, 1 U of ribonuclease H (Pharmacia, Uppsala, Sweden) highlighted by EtBr staining. For increased sensitivity in the was added and the mixture incubated for 1 h at 37°C. The study of glucose and heparin effects, a non-radioactive cDNA pool was serially diluted in water from 155 to 15625. method was used for amplicon detection: after gel separation, The 155 dilution corresponded to 500 ng RNA; hereafter, DNA was transferred onto a nylon membrane (Hybond when a quantity of RNA is indicated as being used in the N+, Amersham Italia Srl, Italy) by means of alkali blotting polymerase chain reaction (PCR), this refers to the generated (0.6 M NaCl, 0.4 M NaOH). After transfer, the nylon memcDNA derived from the quoted RNA amount. Each dilution brane was soaked for 5 min in neutralizing solution (1.5 M was aliquoted in amplification tubes and stored at −20°C NaCl, 0.5 M Tris-HCl (pH 7.2), 1 mM EDTA) and until PCR.
crosslinked by exposure to UV. Specific DNA probes for MMP-2, TIMP-2, a1( IV )COLL and b 2 -microglobulin were PCR obtained by PCR amplifying the cDNA of the HT-1080 human fibrosarcoma cell line, and the respective sequences The 50-ml reaction volumes contained the following: 20 ml of were verified by the dideoxynucleotide chain termination appropriate cDNA dilution, Taq DNA polymerase (1.25 U; method. Probe labelling, membrane hybridization and Pharmacia), dNTPs (0.2 mM each of dTTP, dCTP, dGTP, signal detection were performed by ECL Direct System dATP; Pharmacia) and oligonucleotide primers (0.5 mM (Amersham) following the manufacturer's instructions. each), made up in a final concentration of 1×PCR reaction Autoradiograms were analysed by scanning densitometry buffer (10 mM Tris-HCl (pH 8.3 ), 1.5 mM MgCl 2 , 50 mM using a Hoefer GS 300 densitometer (Hoefer, San Francisco, KCl ) and overlaid with mineral oil. Amplification was per-California). Areas under the curve were calculated by means formed in sequential cycles with 2 min denaturation at 94°C, of software supplied by Hoefer. Comparative analysis was 1 min primer annealing at 56°C and 2 min extension at 72°C; performed for each species on point fitting into the linear after the last cycle, all samples were incubated for an range of amplification ( 8 ng RNA). MMP-2, TIMP-2 and additional 10 min at 72°C. To study the constitutive MMP a1( IV )COLL values from control and treated cultures were and TIMP mRNA expression panel in the mesangial cell then 'normalized' to the corresponding b 2 -microglobulin model systems, amplifications were carried out for 40 cycles. expression (MMP-2/b 2 -microglobulin, etc.; values are then The comparative analysis under glucose and heparin influ-independent from different loading). To evaluate possible ence was based on amplifications from 35 cycles in the case fluctuations of the MMP-2/TIMP-2 balance between differof MMP-2 and TIMP-2, and from 25 cycles in the case of ent culture conditions, the results were expressed using the b 2 -microglobulin and of a1( IV )COLL. following formula which, taking into account variations in Specific human cDNA sequences were amplified using the the expression of both the enzyme and its inhibitor, describes following primers: for MMP-1, residues 1147-1166 (sense any imbalance in favour of either MMP-2 or TIMP-2 under strand ) and 1505-1527 (anti-sense strand), amplification the experimental conditions [8] : product of 381 bp [7] ; for MMP-2, 1800-1819 and 2228-2247, 447 bp [8 ] ; for MMP-9, 1502-1531 and MMP-2 treated /MMP-2 control TIMP-2 treated /TIMP-2 control . 2243-2263, 762 bp [9 ] ; for MMP-10, 120-149 and 899-927,
Statistical analysis
each separately (P<0.001 for both). An example is shown in Fig. 3 . The comparative quantitation of the One-way analysis of variance and Bonferroni's test for amplicons showed no statistical differences, compared multiple comparisons were applied to the results obtained to the control, when glucose and heparin were separfrom quadruplicate experiments.
ately supplemented to the cells ( Fig. 3) . Conversely, when the cells were cultured in the presence of both glucose and heparin, their expression level fell consistResults ently by 71%.
MMPs and TIMPs RT-PCR panel in mesangial cells
Effect of glucose and heparin on MMP-2 and TIMP-2 The human (HMCs) and murine ( MMCs) mesangial mRNA expression in HMCs cell models were characterized for metalloproteinase All treatments (+glucose, +heparin, +glucose+ and tissue inhibitor mRNA expression. Although heparin) significantly reduced MMP-2 mRNA expresquantitative differences were not studied, all tested sion compared to control cells (P<0.001 for all commarkers were constitutively expressed at levels whose parisons), although by different amounts (−68%, amplicons were well detectable after 40 cycles and −29% and −74%, respectively; F=44.63, P=0.000) electrophoresis in agarose gel followed by EtBr stain- (Figs. 3 and 4 ) . In the case of TIMP-2, glucose alone ing. Figure 1 shows the amplification products for or in association with heparin reduced the inhibitor MMP-1, MMP-2, MMP-3, MMP-9, TIMP-1 and mRNA expression by 27% and 36%, respectively TIMP-2 in HMCs. In MMCs the results were equiva-(P<0.001 for both comparisons), while a slightly nonlent, but MMP-10 substitutes MMP-3 (not shown).
significant increase was registered in the case of heparin The expression of a1 (IV )COLL mRNA was also alone (F=27.89, P=0.000). In order to have insights confirmed in HMCs (see below). The results, showing about the potential net proteolytic activity under unique bands for each amplicon, highlight the specifidifferent experimental conditions (although being concity of the chosen primers and the optimization of the scious that messenger quantitation and enzymatic PCR procedure [8] .
activity are not necessarily coincident), the In order to evaluate possible variations in the expres-MMP-2/TIMP-2 mRNA balance was calculated. As sion of the mRNAs under different experimental condishown in Fig. 4 , all treatments consistently reduced the tions, the range over which PCR amplification was protease/inhibitor balance (F=61.68, P=0.000): glulinear was determined by preliminary experiments:
cose the least (−33%), and glucose with heparin the Fig. 2 shows that, for each target molecule, linearity is most (−70%). maintained between 5 and 25 ng of corresponding RNA. Following results were obtained in four separate experiments of which Fig. 3 shows an example. Mean Discussion values and standard deviations are reported in Fig. 4 .
In diabetic nephropathy, the expansion of the mesangEffect of glucose and heparin on type IV collagen ium is closely related to the prognosis of diabetic mRNA expression in HMCs patients, since increased mesangial area is predictive of kidney failure. It is generally considered that mesHMCs showed consistently lower a1( IV )COLL angial expansion in diabetes is due to the extracellular mRNA expression when cultured in the presence of matrix (ECM ) enlargement rather than to mesangial both 30 mM glucose and 100 mg/ml heparin (F=43.38; cell hyperplasia. Indeed, increased matrix synthesis has P=0.000), compared to cultures in the presence of been reported both in vivo in diabetic animals, and in vitro in mesangial cell cultures in high glucose concentrations, or in the presence of advanced glycosylation end products; many of these phenomena have been related to protein kinase C (PKC ) and/or TGFb activation [17, 18] . Increased synthesis of type I, III and IV collagens, laminin and fibronectin have been reported; in particular, the enhanced production of collagen is a central event in diabetic glomerular ECM abnormalities, type IV collagen being one of the first matrix proteins involved [19] . However, matrix regulation is a dynamic process that also involves degradation. The glomerular MMPs are probably the most important proteinases in the degradation of mesangial matrix, and many have been described. mRNAs in primary HMCs ( Fig. 1) , and primary and obtained by 2.5 mg of corresponding total RNA from control human mesangial cells. ing tissue inhibitors, TIMPs. The expression of MMP-2 Indeed, interest is growing concerning the role of matrix degradation in diabetic nephropathy, and the and TIMP-2, which balance has been documented crucial in type IV collagen catabolism [8 ] , is in accord-hypothesis has been forwarded that in its pathogenesis an important role is played by less efficient degradative ance with previous reports: in fact, both have been described by biochemical and molecular biology matrix processes due to the diabetic milieu. An early reduction of glomerular MMPs has been documented methods in HMC cultures and in human glomeruli [20 ] . Our data confirm the expression of MMP-2 and in rat streptozotocine (STZ)-induced diabetes [2 ] , and a 117 kDa MMP has been reported to be most TIMP-2 in HMCs and demonstrate their expression in MMCs as well. As far as MMP-9 is concerned, its involved. In vitro elevated glucose in the media of cultured rat mesangial cells causes suppression of the expression has been only occasionally observed usually after stimulation [20 ] , and never described in MMCs. secretion of transin, a metalloprotease in rats similar to stromelysin [22] , which has a broad spectrum of This paper reports the expression of MMP-9 in both HMCs and MMCs cultured in basal conditions. Also substrates but with a much lower affinity to type IV collagen than MMP-2 [1 ] . the expression of MMP-1 and MMP-10 is described, contrary to a previous report on human mesangial
SV40-transgenic MMCs together with the correspond-
Mesangial cells constitutively express MMP-2, which specifically degrades type IV collagen, its inhibitor cells [20] , but confirming Carome's data with regards to the latter [21 ] . Finally, TIMP-1 mRNA expression TIMP-2 and a1 (IV ), which is mesangial matrix-specific type IV collagen chain [20, present data] . Therefore, in cell lines from both species confirms previous reports. Detection of mRNA in primary and immortal mesangial cells have the potential to completely modulate the synthesis and degradation of the most importlines suggests that the expression of all these molecules is a specific feature of these cells.
ant component of mesangial matrix. We believe it is Glucose and heparin on a1( IV )COLL, MMP-2 and TIMP-2 in mesangial cells 447 have a pivotal position before the activation of different, less specific proteases. For this reason, we have focused attention on the effect of high glucose, a condition simulating the diabetic milieu, on the balance between the expression of a1 (IV )COLL, MMP-2 and TIMP-2. Furthermore, we were also interested to evaluate the effect of heparin because of its recently described effect on diabetic nephropathy [4 ] .
Glucose had no significant effect on collagen mRNA, a result which at first glance might appear surprising in view of in vivo and in vitro reports showing that, in an animal model of diabetes mellitus and in mesangial cell cultures in high glucose, type IV collagen gene is Fig. 3 . RT-PCR amplicons for a1( IV)COLL, MMP-2 and TIMP-2 up-regulated [23, 24] . However, the glucose-dependent been interpreted as the effect of non-enzymatic glycation of mesangial matrix, but direct transfer of the in vitro results to in vivo conditions must be cautiously considered.
Heparin alone does not modify the expression of type IV collagen in mesangial cells, as described in smooth muscle cells [26 ] and observed in the diabetic rat [23] . However, in the presence of high glucose concentration, heparin dramatically down-regulates the type IV collagen gene, a result that resembles in vivo activity [4 ] . Both high glucose concentration and heparin, alone or together, reduced mesangial cell MMP-2 mRNA with a moderate synergistic effect. While TIMP-2 gene expression was unaffected by heparin, and moderately down-regulated by glucose, it appeared consistently reduced by the combination of the two ( Fig. 4) .
As a whole, these data may reflect an unbalanced equilibrium between synthesis and degradation of type IV collagen when mesangial cells are grown either in high glucose or in the presence of heparin, with potentially higher steady-state level of collagen. Although at lower expression level, a new balance between synthesis and degradation is conversely restored when cells are incubated with both, which may better parallel that of control cells. The new equilibrium is mostly due to the down-regulation of type IV collagen expression, rather than further reduc- pretreatment with PMA, supporting the involvement of the PKC cascade in MMP expression. It is worth noting that both high glucose and heparin may intereasy to accept the idea that if something is wrong very early concerning type IV collagen metabolism, mechan-fere with PKC: high glucose concentration is known to increase PKC activity in mesangial cells [27 ] , and isms regulating its steady-state level most likely have to be triggered, and certainly the MMP-2 loop should heparin inhibits this pathway downstream of PKC a 92-kDa type IV collagenase which is identical to that secreted activation [28 ] 
it is expressed constitutively, the MMP-2 is affected [17213] [17214] [17215] [17216] [17217] [17218] [17219] [17220] [17221] neither by PMA nor by heparin [5 ] , suggesting a 10. Muller D, Quantin B, Gesnel M-C, Millon-Collard R, regulatory control other than PKC-dependent control. 
